Sep 17, 2020

Sudden Cardiac Arrest Awareness

Sudden cardiac arrest (SCA) is a sudden, abrupt loss of heart function. Most SCA episodes are caused by the rapid and/or chaotic activity of the heart known as ventricular tachycardia (VT) or ventricular fibrillation (VF). These are abnormalities of the heart’s electrical conduction system. SCA claims the lives of nearly 1,000 Americans each day – many of these deaths are preventable.

The following media kits are made available to provide reporters with background information on the range of Medtronic therapies and the conditions they treat.

 
Oct 13, 2016
Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging
Patients with SureScan® Pacemakers, ICDs and CRT-Ds Now Can Receive 3 Tesla MRI Scans

DUBLIN - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and...
 
May 2, 2016
Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation
Visia AF MRI(TM) SureScan® and Visia AF(TM)ICDs Treat Dangerous Heart Rhythms and Enable Physicians to Identify Patients at Increased Risk for Stroke and Heart Failure Due to AF

DUBLIN - May 2, 2016 - Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the Visia AF MRI(TM) SureScan® and Visia AF(TM)...
 
Sep 14, 2015
Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System
Evera MRI ICD System Approved for Use During Full Body MRI Scans for Patients at Risk of Sudden Cardiac Arrest

DUBLIN - Sept. 14, 2015 - Medtronic plc (NYSE: MDT) today announced that it has received the first U.S. Food and Drug Administration (FDA) approval for an implantable cardioverter defibrillator...
 
Jan 29, 2015
Studies Show Benefits of Medtronic SmartShock(TM) Technology and Physician Reports in Protecting Patients from Inappropriate Shocks
New Results from PainFree SST, Shock-Less Studies, Involving Nearly 7,000 Patients, Published in HeartRhythm

DUBLIN and MINNEAPOLIS - Jan. 29, 2015 - Medtronic plc (NYSE: MDT) today announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm. The data...